» Articles » PMID: 19575230

The Putative Cyclooctadepsipeptide Receptor Depsiphilin of the Canine Hookworm Ancylostoma Caninum

Overview
Journal Parasitol Res
Specialty Parasitology
Date 2009 Jul 4
PMID 19575230
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The G-Protein-coupled receptor Hc110-R of Haemonchus contortus and its orthologue in Caenorhabditis elegans, the latrophilin-like protein 1 (LAT-1), were shown to play a role in the mode of action of the new anthelmintic compound emodepside. C. elegans LAT-1 knockout mutants showed a decreased paralysing effect of emodepside on the pharyngeal muscle. In the present study, the LAT-1 orthologue in the canine hookworm Ancylostoma caninum was identified and named depsiphilin. To obtain more information about the regulation of this receptor and to facilitate phylogenetic and evolutionary analyses of parasitic nematode genes, the genomic structure of A. caninum depsiphilin was investigated. High consistency regarding the position of introns in comparison to C. elegans LAT-1 was observed, providing indication of the same origin of the genes. With a view to possible differences in efficacy of emodepside on different developmental stages, we analysed the transcript level of A. caninum depsiphilin in eggs, L1, L3, male and female adult worms using quantitative real-time PCR. Depsiphilin is transcribed in all five examined stages, but we found a significantly lower transcript level in third-stage larvae. A correlation between these findings and a reduced emodepside activity remains to be investigated.

Citing Articles

Efficacy evaluation of anthelmintic products against an infection with the canine hookworm (Ancylostoma caninum) isolate Worthy 4.1F3P in dogs.

Jimenez Castro P, Mansour A, Charles S, Hostetler J, Settje T, Kulke D Int J Parasitol Drugs Drug Resist. 2020; 13:22-27.

PMID: 32403053 PMC: 7214830. DOI: 10.1016/j.ijpddr.2020.04.003.


Evaluation of emodepside in laboratory models of human intestinal nematode and schistosome infections.

Karpstein T, Pasche V, Haberli C, Scandale I, Neodo A, Keiser J Parasit Vectors. 2019; 12(1):226.

PMID: 31088525 PMC: 6515646. DOI: 10.1186/s13071-019-3476-x.


Parasite neuropeptide biology: Seeding rational drug target selection?.

McVeigh P, Atkinson L, Marks N, Mousley A, Dalzell J, Sluder A Int J Parasitol Drugs Drug Resist. 2014; 2:76-91.

PMID: 24533265 PMC: 3862435. DOI: 10.1016/j.ijpddr.2011.10.004.


Ion channels and receptor as targets for the control of parasitic nematodes.

Wolstenholme A Int J Parasitol Drugs Drug Resist. 2014; 1(1):2-13.

PMID: 24533259 PMC: 3898135. DOI: 10.1016/j.ijpddr.2011.09.003.


Current drug targets for helminthic diseases.

Rana A, Misra-Bhattacharya S Parasitol Res. 2013; 112(5):1819-31.

PMID: 23529336 DOI: 10.1007/s00436-013-3383-6.


References
1.
LARKIN M, Blackshields G, Brown N, Chenna R, McGettigan P, McWilliam H . Clustal W and Clustal X version 2.0. Bioinformatics. 2007; 23(21):2947-8. DOI: 10.1093/bioinformatics/btm404. View

2.
Guest M, Bull K, Walker R, Amliwala K, OConnor V, Harder A . The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans. Int J Parasitol. 2007; 37(14):1577-88. DOI: 10.1016/j.ijpara.2007.05.006. View

3.
Prachumwat A, DeVincentis L, Palopoli M . Intron size correlates positively with recombination rate in Caenorhabditis elegans. Genetics. 2004; 166(3):1585-90. PMC: 1470791. DOI: 10.1534/genetics.166.3.1585. View

4.
Breathnach R, Chambon P . Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem. 1981; 50:349-83. DOI: 10.1146/annurev.bi.50.070181.002025. View

5.
Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J . qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007; 8(2):R19. PMC: 1852402. DOI: 10.1186/gb-2007-8-2-r19. View